Published • loading... • Updated
Breakthrough Properties Buys Biomanufacturing Facility Near Seattle for $78M
Summary by REBusinessOnline
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Breakthrough Properties Buys Biomanufacturing Facility Near Seattle for $78M
EVERETT, WASH. — Breakthrough, a joint venture of Tishman Speyer and Bellco Capital, has acquired a biomanufacturing facility in Everett, a suburb of Seattle, for $78 million. In tandem with the acquisition, Breakthrough secured a separate 21-year lease for the entire campus with a global biopharmarceutical company to create a U.S. manufacturing facility. The 270,000-square-foot facility can support a range of uses, including drug manufacturing,…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
